However, because Leqembi is subject to the NCD for Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease under coverage with evidence development (CED), [241] and because Leqembi was initially marketed and sold under accelerated approval, Leqembi coverage under Part B required the product to be furnished in a randomized controlled trial (RCT) conducted under an investigational new drug (IND) application
Nicotine absorption is influenced by several factors, including concentration, moisture content, flavorings, and pH
Ischemic heart disease For ischemic heart disease, we identified eight unique studies with nine eligible observations used to inform our primary analysis (Fig
Flavor profile: A sharp, zesty lemon note hits first with a slight tang
37 Similar results have been observed in trials using combination therapy with sustained-release bupropion and the nicotine patch